Anti-CD20 antibody-related pyoderma gangrenosum

被引：0
|
作者：
机构：
来源：
Reactions Weekly | 2024年 / 2016卷 / 1期
关键词：
D O I：
10.1007/s40278-024-62495-z
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：2 / 2
相关论文
共 50 条
  • [21] Rituximab (monoclonal anti-CD20 antibody): mechanisms of action and resistance
    Mitchell R Smith
    Oncogene, 2003, 22 : 7359 - 7368
  • [22] Combination therapy with the type II anti-CD20 antibody obinutuzumab
    Klein, Christian
    Bacac, Marina
    Umana, Pablo
    Fingerle-Rowson, Gunter
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2017, 26 (10) : 1145 - 1162
  • [23] The use of rituximab, anti-CD20 monoclonal antibody, in pediatric transplantation
    Pescovitz, MD
    PEDIATRIC TRANSPLANTATION, 2004, 8 (01) : 9 - 21
  • [24] The Labelling of Monoclonal Antibody Anti-CD20 with Yttrium and Lutetium Radionuclides
    Budsky, Frantisek
    Miler, Vlastimil
    Malek, Zdenek
    CHEMICKE LISTY, 2009, 103 (01): : 76 - 80
  • [25] Secondary antibody deficiency: a complication of anti-CD20 therapy for neuroinflammation
    Tallantyre, E. C.
    Whittam, D. H.
    Jolles, S.
    Paling, D.
    Constantinesecu, C.
    Robertson, N. P.
    Jacob, A.
    JOURNAL OF NEUROLOGY, 2018, 265 (05) : 1115 - 1122
  • [26] Rituximab, an anti-CD20 monoclonal antibody: History and mechanism of action
    Pescovitz, MD
    AMERICAN JOURNAL OF TRANSPLANTATION, 2006, 6 (05) : 859 - 866
  • [27] The anti-CD20 monoclonal antibody rituximab to treat acquired haemophilia A
    D'Arena, Giovanni
    Grandone, Elvira
    Di Minno, Matteo N. D.
    Musto, Pellegrino
    Di Minno, Giovanni
    BLOOD TRANSFUSION, 2016, 14 (03) : 255 - 261
  • [28] Anti-CD20 Antibody Therapy for B-Cell Lymphomas
    Maloney, David G.
    NEW ENGLAND JOURNAL OF MEDICINE, 2012, 367 (09): : 878 - 878
  • [29] Secondary antibody deficiency: a complication of anti-CD20 therapy for neuroinflammation
    E. C. Tallantyre
    D. H. Whittam
    S. Jolles
    D. Paling
    C. Constantinesecu
    N. P. Robertson
    A. Jacob
    Journal of Neurology, 2018, 265 : 1115 - 1122
  • [30] Fatal neurological side effect of anti-CD20 antibody treatment
    Schmidt, Kathie
    Skusa, Romy
    Grossmann, Annette
    INNERE MEDIZIN, 2023, 64 (02): : 193 - 196
12345